Optimal management, prevalence, and clinical behavior of saddle pulmonary embolism: A systematic review and meta-analysis. Issue 217 (September 2022)
- Record Type:
- Journal Article
- Title:
- Optimal management, prevalence, and clinical behavior of saddle pulmonary embolism: A systematic review and meta-analysis. Issue 217 (September 2022)
- Main Title:
- Optimal management, prevalence, and clinical behavior of saddle pulmonary embolism: A systematic review and meta-analysis
- Authors:
- Ata, Fateen
Ibrahim, Wanis H.
Choudry, Hassan
Shams, Abdullah
Arshad, Abdullah
Younas, Hafiz Waqas
Bilal, Ammara Bint I.
Ikram, Muhammad Qaiser
Tahir, Shuja
Mogassabi, Waqar W.
Errayes, Nada Mehdi - Abstract:
- Abstract: Introduction: The central location, size, and instability of saddle pulmonary embolism (SPE) have raised significant concerns regarding its clinical, hemodynamic effects as well as optimal management. Pulmonary embolism (PE) guidelines barely address such concerns. We aimed to pool the available data on the clinical behavior and outcomes of SPE and study the effects of various treatment modalities on mortality outcomes. Methods: PubMed, Scopus, and Google Scholar were searched for articles (any date up to February 28, 2022) reporting patients with SPE. Data on SPE demographics, clinical characteristics, management, and outcomes were extracted and analyzed. Results: Results from all SPE cases: A total of 5251 patients from 194 studies were included in the review. Dyspnea (57 %) was the most prevalent symptom. Massive and submassive PE comprised 9.7 % and 45.8% of cases, respectively. Thrombolytic therapy (TT) was administered in 18.1 %, and thrombectomy was performed in 16 % of cases. SPE-related mortality was observed in 4.6 %, late decompensation in 9.5 %, and PE recurrence in 4.5 % of cases. Female sex (61.5 % vs. 41.3 %, p = 0.019), hypoxemia (90 % vs. 59.2 %, p < 0.001), massive PE features (89.7 % vs. 30.1 %, p < 0.001), associated chronic kidney disease (CKD) (10.3 % vs. 1.4 %, p = 0.002), and the need for mechanical ventilation (28.2 % vs. 13.1 %, p = 0.02) were significantly associated with increased mortality. The use of TT was significantlyAbstract: Introduction: The central location, size, and instability of saddle pulmonary embolism (SPE) have raised significant concerns regarding its clinical, hemodynamic effects as well as optimal management. Pulmonary embolism (PE) guidelines barely address such concerns. We aimed to pool the available data on the clinical behavior and outcomes of SPE and study the effects of various treatment modalities on mortality outcomes. Methods: PubMed, Scopus, and Google Scholar were searched for articles (any date up to February 28, 2022) reporting patients with SPE. Data on SPE demographics, clinical characteristics, management, and outcomes were extracted and analyzed. Results: Results from all SPE cases: A total of 5251 patients from 194 studies were included in the review. Dyspnea (57 %) was the most prevalent symptom. Massive and submassive PE comprised 9.7 % and 45.8% of cases, respectively. Thrombolytic therapy (TT) was administered in 18.1 %, and thrombectomy was performed in 16 % of cases. SPE-related mortality was observed in 4.6 %, late decompensation in 9.5 %, and PE recurrence in 4.5 % of cases. Female sex (61.5 % vs. 41.3 %, p = 0.019), hypoxemia (90 % vs. 59.2 %, p < 0.001), massive PE features (89.7 % vs. 30.1 %, p < 0.001), associated chronic kidney disease (CKD) (10.3 % vs. 1.4 %, p = 0.002), and the need for mechanical ventilation (28.2 % vs. 13.1 %, p = 0.02) were significantly associated with increased mortality. The use of TT was significantly associated with increased survival (27.1 % vs. 12.5 %, p < 0.001). In a multivariate logistic regression model, massive PE features significantly increased the odds of death (OR: 29.3, CI: 4.86–181.81, p < 0.001), whereas, treatment with anticoagulation (AC) alone (OR: 0.1, CI: 0.027–0.356, p < 0.001), TT (OR: 0.065, CI: 0.019–0.26, p < 0.001), surgical thrombectomy (ST) (OR: 0.047, CI: (0.010–0.23), p < 0.001), or percutaneous thrombectomy (PT) (OR: 0.12, CI: 0.020–0.84, p = 0.032) significantly decreased odds of death. Results from a meta-analysis of observational studies: Meta-analysis of the included 17 observational studies revealed an overall 10 % (95 % CI: 4.56–16.89) SPE prevalence among all PE cases. The overall SPE-related mortality rate was 8 % (95 % CI: 5.26–10.96). Massive PE was observed in 13.3 % (95 % CI: 5.56–23.70), PE recurrence in 5.1 % (95 % CI: 2.22–9.05), and late decompensation in 11 % (95 % CI: 3.43–22.34) of patients. Conclusions: SPE comprises 10 % of all PE cases. Despite its ominous radiologic appearance, the clinical, hemodynamic, and mortality outcomes of SPE seem comparable to that of other PE types in general. The presence of massive PE features is the main predictor of mortality in SPE patients. AC, TT, ST, and PT are all associated with decreased odds of death from SPE. Highlights: This is the first sizeable and comprehensive systematic review and meta-analysis addressing saddle pulmonary embolism. Saddle pulmonary embolism comprises 10% of all pulmonary embolism cases. Despite its ominous radiologic appearance, clinical behavior and mortality from saddle pulmonry embolism are comparable to other pulmonary embolism types. The presence of massive pulmonary embolism features is the main predictor of mortality in saddle pulmonary embolism. Anticoagulation alone, thrombolytic therapy, surgical thrombectomy, and percutaneous thrombectomy are all associated with decreased odds of death. … (more)
- Is Part Of:
- Thrombosis research. Issue 217(2022)
- Journal:
- Thrombosis research
- Issue:
- Issue 217(2022)
- Issue Display:
- Volume 217, Issue 217 (2022)
- Year:
- 2022
- Volume:
- 217
- Issue:
- 217
- Issue Sort Value:
- 2022-0217-0217-0000
- Page Start:
- 86
- Page End:
- 95
- Publication Date:
- 2022-09
- Subjects:
- Saddle pulmonary embolism -- Pulmonary embolism -- Thrombolysis
Thrombosis -- Periodicals
616.135 - Journal URLs:
- http://www.sciencedirect.com/science/journal/00493848 ↗
http://www.elsevier.com/journals ↗ - DOI:
- 10.1016/j.thromres.2022.07.013 ↗
- Languages:
- English
- ISSNs:
- 0049-3848
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 8820.365000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 23553.xml